Amgen patent revoked in 17 countries by Unified Patent Court in win for Sanofi-Aventis
MLex Summary: A patent associated with Amgen's cholesterol-lowering drug Repatha is obvious, the Unified Patent Court declared in a revocation action initiated by Sanofi-Aventis. See document below....To view the full article, register now.
Already a subscriber? Click here to view full article